• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Dakshu Jindal, MA

Latest:

Effect of Care Coordination on Patients With Alzheimer Disease and Their Caregivers

The authors investigated whether patient coordination and caregiver support for Alzheimer disease reduced health care utilization and expenditures among enrollees in the Memory Program in South Carolina.


Manish Chadha, MD, MBA

Latest:

COVID-19 and Clinic Workflow Optimization Using Lean Six Sigma

The authors report an approach of outpatient clinic workflow reorganization utilizing simple, inexpensive measures to improve patient engagement and experience in addition to providing a safe setting for patients for clinic visits in the wake of COVID-19.


Jonathan Staloff, MD, MSc

Latest:

Primary Care Moonshot: A Policy Proposal for Addressing Underinvestment in Primary Care

A Primary Care Moonshot could reorient the US health care system to a system of wellness and prevention, with long-term savings in care expenditures and better health outcomes.


Sara D. Turbow, MD, MPH

Latest:

Impact of Electronic Information Exchange on Repeat Imaging During 30-Day Readmissions Among Medicare Beneficiaries

This analysis of Medicare data examines the relationships between fragmented readmission, health information exchange, and repeat imaging in older adults with and without Alzheimer disease.


Om Dave, BS

Latest:

Incidence and Cost of Potentially Avoidable Emergency Department Visits for Urolithiasis

This study characterizes the incidence and associated factors of urolithiasis-related emergency department visits that are potentially preventable with appropriate ambulatory care and calculates their cumulative costs.


Wenhua Shi, PhD

Latest:

Determinants of ICS Therapy Adherence in Patients With Asthma

This study describes determinants affecting disease control and inhaled glucocorticosteroid therapy adherence for patients with asthma in western China.


Maryann Vienneau, BS

Latest:

Intensive Care Management of a Complex Medicaid Population: A Randomized Evaluation

The authors present findings of a randomized evaluation of Medicaid patients at an academic medical center, which found that intensive care management was associated with reduced total medical expense.


Kristi Ressel, MPH

Latest:

Provider Capacity During Medicaid Expansion and a Public Health Emergency

This survey study finds that most Missouri Medicaid providers had capacity for new patients, even during a period of unprecedented Medicaid enrollment growth.


Mollyn Shew

Latest:

Dallas Nephrology Associates’ Journey to Value-Based Care

Preventing or delaying the onset of end-stage kidney disease is vital. By implementing a results-driven, value-based approach, Dallas Nephrology Associates has demonstrated improved patient outcomes and value for payers.


Stephanie Parker, PharmD

Latest:

Access Denied: CMS’ Action Hurts Patients With Cancer in Rural America

CMS rules hindered the access of rural patients with cancer to medically integrated pharmacies in 2023. The authors discuss the impact on equity in health care, emphasizing the need for regulatory change.


Traci J. LeMasters, PhD

Latest:

Initial Maintenance Therapy Adherence Among Older Adults With Asthma-COPD Overlap

Older adults with coexisting asthma and chronic obstructive pulmonary disease (COPD), known as asthma-COPD overlap, who take fixed-dose combinations of inhaled corticosteroids and long-acting β agonists may be less likely to have persistent low adherence to initial maintenance therapy.


Ronald S. Go, MD

Latest:

Provider Barriers in Uptake of Biosimilars: Case Study on Filgrastim

Previous studies have found modest uptake of biosimilars in both commercial and Medicare populations. This study finds that the uptake varies between the rural and urban provider settings.



Catherine S. Hwang, MD, MSPH

Latest:

Bridging to Value With Codes That Promote Care Management

Fee-for-service billing codes can serve as bridges for organizations to build care management capabilities and transition from volume- to value-based payment and care delivery.


Jacques Turgeon, BPharm, PhD

Latest:

Revisiting Conclusions on the Empiric Segmentation of High-risk Patients

The authors provide feedback on generalizations made regarding interventions for high-risk populations in previous research.


Elzbieta Dziekonski, RN
Elzbieta Dziekonski, RN

Latest:

Contributor: The Diabetes Vendor Resource Guide—A Useful Directory for Employers

Employees living with diabetes often face unique challenges, such as managing blood sugar levels, balancing medication, and preventing complications, all while maintaining their professional responsibilities. This condition can lead to increased absenteeism, reduced productivity, and rising health care costs.


Jaime E. Murillo, MD

Latest:

Evidence Supporting 2024 Guidance for Lp(a) Testing

Experts discuss the evidence supporting the National Lipid Association’s (NLA) recommendation for universal lipoprotein(a) (Lp[a]) measurement and evaluate how compelling this evidence is from a clinical perspective.


Steven M. Stein, MD

Latest:

Interventional Analytics in Skilled Nursing Facilities Associated With Reduced Readmissions

A retrospective analysis of 30-day risk-adjusted readmission rates among skilled nursing facilities (SNFs) between 2017 and 2022 compared those that had implemented an interventional analytics platform and other SNFs.


Rocco Ricciardi, MD

Latest:

Potential Impact of Hospital at Home on Postoperative Readmissions

Many postoperative readmissions are amenable to diversion to a hospital at home program for surgical patients, representing an opportunity to generate revenue and improve patient experience.


Erica Galvez, MA

Latest:

Incentivizing Data Sharing Among Health Plans, Hospitals, and Providers to Improve Quality

Health plans can gain efficiencies and improve quality by connecting to health information networks and incentivizing hospital and provider participation as part of pay-for-performance programs.


Sub Subramony, M.D.

Latest:

Future Considerations for Friedreich Ataxia

Sub Subramony, M.D., discusses strategies to enhance support for patients with Friedreich ataxia in clinical settings and the broader community, along with his aspirations for future research aimed at addressing unmet needs in treatment and patient support.


Mary Stilphen, DPT

Latest:

High-Intensity Home-Based Rehabilitation in a Medicare Accountable Care Organization

High-intensity home-based rehabilitation (HIHR) may substitute for facility-based postacute rehabilitation. Patients in HIHR had better functional outcomes at lower costs than patients in facility-based care.


Rebecca Vasquez, MD

Latest:

Addressing Social Determinants of Health Improves Dermatologic Care in Underserved Populations

Rebecca Vasquez, MD, FAAD, University of Texas Southwestern Medical Center, emphasizes the necessity of addressing social determinants to improve dermatological care and access for underserved populations.


Terry Wilcox

Latest:

Where Have All the Doctors Gone? Medicare Physician Payment Cuts Threaten Patient Access to Quality Care

The author calls on Congress to address reimbursement shortfalls that are contributing to a growing physician shortage, with rural areas the hardest hit.


John Heymach, MD, PhD

Latest:

Key Takeaways on Enhancing Outcomes for mNSCLC Without Targetable Driver Mutations

The panel provides insights on enhancing outcomes for patients with metastatic non-small cell lung cancer without targetable driver mutations.


Sema Sgaier, PhD

Latest:

Better Data Is Needed to Tackle Health Equity

The US federal government is finally updating its standards for reporting data on race and ethnicity – and it’s an urgently needed chance to enable a national overview of crucial data on health inequities



Kael Wherry, PhD

Latest:

Cost-Effectiveness of the MiniMed 780G System for Type 1 Diabetes

A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.



Stuart Genschaw, MBA

Latest:

AJMC Roundtable: Evaluating the Management of Cancer Immunotherapy (CIT)

Stuart Genschaw, MBA, discusses how his practice approaches cancer immunotherapy (CIT) management and the potential future pathways of care.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.